The Next Generation of Mouse Model Preparation Platform
Global Vision & Partnership
International VeloGene Biotechnology Co., Ltd
國際維洛基因生物技術有限公司
At VeloGene, our vision is to bridge the gap between cutting-edge gene-editing breakthroughs and global laboratory accessibility, fostering a truly interconnected scientific ecosystem. As a dedicated international arm of MingCeler Biotech, we are uniquely positioned to translate the transformative potential of the patented TurboMice™ technology into tangible research advantages for labs across the globe.
We aim to redefine the standard of excellence in gene-edited model generation by providing researchers with unparalleled technical precision, faster project turnaround times, and unwavering scientific support. At the heart of everything we do is a singular goal: to empower the international scientific community with the tools they need to overcome the most daunting research hurdles. By shortening the distance between a hypothesis and a discovery, VeloGene is committed to ensuring that the next generation of groundbreaking breakthroughs happens faster, ensuring that scientific progress knows no borders.



VeloGene Biotechnology and Its Partners
GenAssist Ltd and International VeloGene Biotechnology Co., Ltd have officially announced a strategic global partnership to provide researchers and pharmaceutical developers with access to validated, humanized Duchenne muscular dystrophy (DMD) mouse models.
Powered by VeloGene's advanced TurboMice™ technology, this collaboration aims to address critical bottlenecks in preclinical drug development for rare muscle diseases. By offering highly reliable and rapid humanized DMD models globally, the initiative empowers researchers to accelerate the translation of breakthrough therapies, streamline drug efficacy testing, and improve therapeutic outcomes for patients suffering from Duchenne muscular dystrophy worldwide.
VeloGene Biotechnology's Awards

















